Hepatitis C

Michael Banks, MD, on Relaxed Criteria for Medicaid Program Increases DAA Treatment Use in HCV

Michael Banks, MD, talks about how 2016 Medicaid criteria has allowed for increased access to direct-acting antiviral therapies among patients with hepatitis C virus for whom the costs of the treatments were too high.

For more videos, visit our partners at The Doctor's Channel.